Profile: Cytovax Biotechnologies Inc. is a biotechnology company focused on the development of approaches for the prevention & treatment of infectious diseases using its proprietary anti-adhesion platform technology. Our anti-adhesion technology and coiled-coil technology can be used to develop vaccines. Cytovaxine is our peptide conjugate vaccine for the prevention of infections caused by pseudomonas aeruginosa.

The company was founded in 1998, has revenues of < USD 1 Million, has ~10 employees.